A Lipid-Soluble Red Ginseng Extract Inhibits the Growth of Human Lung Tumor Xenografts in Nude Mice

被引:34
作者
Lee, Sung Dong [2 ]
Park, Song-Kyu [4 ]
Lee, Eun Sil [5 ,6 ]
Kim, Hwan Mook [4 ]
Lee, Chang Woo [4 ]
Lee, Kiho [4 ]
Lee, Ki Hoon [4 ]
Kang, Moo Rim [4 ]
Lee, Kwang Seung [5 ]
Lee, Junsoo [6 ]
Hwang, Woo Ik [3 ]
Kim, Dong Chung [1 ,7 ]
机构
[1] Chungwoon Univ, Dept Human Nutr & Food Sci, Hongseong 350701, South Korea
[2] Korea Univ, Coll Hlth Sci, Dept Food & Nutr, Seoul, South Korea
[3] Korea Univ, Coll Med, Dept Biochem, Seoul, South Korea
[4] Korea Res Inst Biosci & Biotechnol, Bioevaluat Ctr, Ochang, South Korea
[5] NH Hansamin Co Ltd, Jeungpyeong, South Korea
[6] Chungbuk Natl Univ, Dept Food Sci & Technol, Cheongju, South Korea
[7] Sungkyunkwan Univ, Inst Basic Sci, Suwon, South Korea
关键词
anticancer effect; human tumor xenograft; lipid-soluble ginseng extract; oral administration; CELL-PROLIFERATION; CANCER CELLS; INDUCTION; APOPTOSIS; SURVIVAL; RH-2; RATS;
D O I
10.1089/jmf.2009.1142
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Lipid-soluble ginseng extract was prepared by n-hexane extraction of red ginseng. BALB/c-nu mice were inoculated with human lung cancer (NCI-H460) cells to establish a human tumor xenograft model in nude mice, and the lipid-soluble ginseng extract was orally administered. The tumor inhibitory rates of the lipid-soluble ginseng extract at doses of 0.1, 0.3, and 1.0 g/kg/day were 18.9% (P<.05), 60.0% (P<.001), and 67.5% (P<.001), respectively. The oral administration of the lipid-soluble extract of red ginseng showed a potent anticancer effect in nude mice bearing human lung cancer cells in a dose-dependent manner without any apparent toxicity. This lipid-soluble ginseng extract is a potential nontoxic anticancer supplement for the prevention and intervention of lung tumor growth through an oral administration route.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 31 条
[1]   Ascorbic acid and α-tocopherol protect anticancer drug cisplatin induced nephrotoxicity in mice:: a comparative study [J].
Ajith, T. A. ;
Usha, S. ;
Nivitha, V. .
CLINICA CHIMICA ACTA, 2007, 375 (1-2) :82-86
[2]  
[Anonymous], BIOTECHNOL BIOPROCES
[3]  
[Anonymous], 2004, IDENTIFICATION ESSEN
[4]   Ginseng pharmacology - Multiple constituents and multiple actions [J].
Attele, AS ;
Wu, JA ;
Yuan, CS .
BIOCHEMICAL PHARMACOLOGY, 1999, 58 (11) :1685-1693
[5]   Temporal changes of lung cancer mortality in Korea [J].
Choi, Yunhee ;
Kim, Yeonju ;
Hong, Yun-Chul ;
Park, Sue Kyung ;
Yoo, Keun-Young .
JOURNAL OF KOREAN MEDICAL SCIENCE, 2007, 22 (03) :524-528
[6]   Association of ginseng use with survival and quality of life among breast cancer patients [J].
Cui, Y ;
Shu, XO ;
Gao, YT ;
Cai, H ;
Tao, MH ;
Zheng, W .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (07) :645-653
[7]   Efficacy of oral and intraperitoneal administration of CBMIDA for removing uranium in rats after parenteral injections of depleted uranium [J].
Fukuda, S. ;
Ikeda, M. ;
Nakamura, M. ;
Yan, X. ;
Xie, Y. .
RADIATION PROTECTION DOSIMETRY, 2009, 133 (01) :12-19
[8]   Inhibition by ginseng of colon carcinogenesis in rats [J].
Fukushima, S ;
Wanibuchi, H ;
Li, W .
JOURNAL OF KOREAN MEDICAL SCIENCE, 2001, 16 :S75-S80
[9]  
Helms Steve, 2004, Altern Med Rev, V9, P259
[10]  
Hwang WI, 1993, KOREAN J GINSENG SCI, V17, P52